Inuprin Forte, 30 tabl.

Inuprin Forte

Indications:

Inuprin Forte is an antiviral drug with immunostimulating effect, indicated for oral use in adults and children over 1 year of age:

• in case of recurrent respiratory infections;
• for people with reduced immunity;
• in the treatment of cold sores on the lips and face caused by the herpes simplex virus (only in patients who have previously been diagnosed with herpes simplex virus infection).

Properties: 

The drug Inuprin Forte contains inosine pranobex as an active substance, which has antiviral and immune system stimulating effects. The drug’s action is primarily based on stimulating the cellular response of the immune system associated with T-lymphocytes. It supports the accumulation and activation of cells participating in the immune response: neutrophils, monocytes and macrophages. After oral administration, it is quickly and almost completely absorbed from the gastrointestinal tract.

Ingredients:

Active substance: inosine pranobex (a complex containing inosine and 2-hydroxypropyldimethylammonium 4-acetamidobenzoate in a molar ratio of 1:3).

• One tablet contains 1000 mg of inosine pranobex.

The other ingredients are: microcrystalline cellulose, croscarmellose sodium, polyvinylpyrrolidone K90, magnesium stearate.

Use:

The medicine should be taken orally. The tablet should be taken with a large amount of liquid, preferably water. The tablet can be crushed and dissolved in a small amount of water.

The recommended dose is based on the patient’s body weight. The daily dose should be divided into equal single doses administered several times a day.

• Adults: 50 mg/kg body weight daily in several equal divided doses; usually 1 g (1 tablet) 3 times daily. The maximum dose is 4 g daily (i.e. 1 tablet 4 times daily).
• Children over 1 year of age: 50 mg/kg body weight per day in 3–4 divided doses. For children who cannot swallow tablets, a syrup formulation is recommended.

Treatment usually lasts 5–14 days; the medicine should be used for another 1–2 days after the symptoms have subsided. If there is no improvement after 5–14 days, consult a doctor.

Important information:

Do not exceed the recommended daily dose. Do not use in case of hypersensitivity to any of the ingredients.

Do not use in people who are currently experiencing a gout attack or increased levels of uric acid in the blood.

Do not use in children under 1 year of age.

The preparation should not be used by pregnant or breastfeeding women unless the doctor considers it absolutely necessary.

Packaging:

30 tablets